Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Substance Misuse To Psychosis for Stimulants (SToP-S)--An Early Assertive Pharmacotherapy Intervention Study

Trial Profile

Substance Misuse To Psychosis for Stimulants (SToP-S)--An Early Assertive Pharmacotherapy Intervention Study

Not yet recruiting
Phase of Trial: Phase II/III

Latest Information Update: 12 Sep 2018

At a glance

  • Drugs Aripiprazole (Primary) ; Aripiprazole (Primary) ; Paliperidone (Primary) ; Paliperidone (Primary)
  • Indications Psychotic disorders; Substance-related disorders
  • Focus Therapeutic Use
  • Acronyms SToP-S
  • Most Recent Events

    • 31 Aug 2018 Planned End Date changed from 31 Dec 2021 to 31 Mar 2022.
    • 31 Aug 2018 Planned primary completion date changed from 30 Sep 2021 to 30 Dec 2021.
    • 31 Aug 2018 Planned initiation date changed from 1 Aug 2018 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top